{"transactions":[{"id":1488133,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-06T20:36:14.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":9826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":9826,"derivative":{"underlying":"Common Stock","underlying_shares":9826},"source":{"system":"sec-edgar","filing":"0000950170-24-069934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024069934/ownership.xml","form_type":"4"}},{"id":1524471,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-07T20:26:03.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":4202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4202},"source":{"system":"sec-edgar","filing":"0000950170-24-054584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024054584/ownership.xml","form_type":"4"}},{"id":1524470,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-07T20:26:03.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":4202,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting and settlement of Restricted Stock Units (\"RSUs\") on May 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split."}],"balance_after":4202,"source":{"system":"sec-edgar","filing":"0000950170-24-054584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024054584/ownership.xml","form_type":"4"}},{"id":1900705,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-08T20:15:22.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":126075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":126075,"derivative":{"underlying":"Common Stock","underlying_shares":126075},"source":{"system":"sec-edgar","filing":"0001209191-23-027928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123027928/doc4.xml","form_type":"4"}},{"id":2273195,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-12T11:16:46.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":156951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":156951,"derivative":{"exercise_price":1.86,"expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":156951},"source":{"system":"sec-edgar","filing":"0001209191-22-028451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122028451/doc4.xml","form_type":"4"}},{"id":2517483,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-10T21:17:37.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":55360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 substantially equal monthly installments following November 8, 2021, such that the option shall be fully vested on November 8, 2024."}],"balance_after":55360,"derivative":{"exercise_price":9.66,"expiration_date":"2031-11-07","underlying":"Common Stock","underlying_shares":55360},"source":{"system":"sec-edgar","filing":"0001209191-21-063848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121063848/doc4.xml","form_type":"4"}},{"id":4169912,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:12:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option, which vests in equal monthly installments over 48 months beginning January 18, 2017, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option, which vests in equal monthly installments over 48 months beginning January 18, 2017, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.9,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-059634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059634/doc4.xml","form_type":"4"}},{"id":4169911,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:12:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This stock option, which vests in equal monthly installments over 48 months beginning January 27, 2016, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option, which vests in equal monthly installments over 48 months beginning January 27, 2016, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.14,"expiration_date":"2026-01-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-059634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059634/doc4.xml","form_type":"4"}},{"id":4169910,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-11-07T17:12:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":278035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx, in exchange for a cash payment of $6.00 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-059634","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059634/doc4.xml","form_type":"4"}},{"id":4467834,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":90192,"kind":"person","name":"Wadsworth Samuel C.","position":1,"cik":"0001653056","reported_name":"Wadsworth Samuel C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-03T16:43:28.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in forty-eight (48) equal monthly installments beginning on January 18, 2017."}],"balance_after":60000,"derivative":{"exercise_price":1.9,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-007660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117007660/doc4.xml","form_type":"4"}}]}